104 related articles for article (PubMed ID: 38772955)
1. Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.
Nakamori Y; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K; Nakahashi N; Sekiguchi S; Tsuchihashi K; Miyazaki A; Osanai M
Med Mol Morphol; 2024 May; ():. PubMed ID: 38772955
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer.
Kamiya S; Nakamori Y; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K; Osanai M
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36928289
[TBL] [Abstract][Full Text] [Related]
3. CYP24A1-induced vitamin D insufficiency promotes breast cancer growth.
Osanai M; Lee GH
Oncol Rep; 2016 Nov; 36(5):2755-2762. PubMed ID: 27600601
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma.
Shiratsuchi H; Wang Z; Chen G; Ray P; Lin J; Zhang Z; Zhao L; Beer D; Ray D; Ramnath N
J Thorac Oncol; 2017 Feb; 12(2):269-280. PubMed ID: 27793774
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy.
Kamiya S; Nakamori Y; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K; Osanai M
Med Mol Morphol; 2023 Jun; 56(2):85-93. PubMed ID: 36749415
[TBL] [Abstract][Full Text] [Related]
6. Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas.
Shintani T; Rosli SNZ; Takatsu F; Choon YF; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2016 Nov; 164():79-84. PubMed ID: 26444325
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucocorticoids on vitamin D
Zayny A; Almokhtar M; Wikvall K; Ljunggren Ö; Ubhayasekera K; Bergquist J; Kibar P; Norlin M
Mol Cell Endocrinol; 2019 Oct; 496():110525. PubMed ID: 31352041
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1,25 and 24,25 Vitamin D on Corneal Epithelial Proliferation, Migration and Vitamin D Metabolizing and Catabolizing Enzymes.
Lu X; Chen Z; Mylarapu N; Watsky MA
Sci Rep; 2017 Dec; 7(1):16951. PubMed ID: 29208972
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.
Balla B; Tobiás B; Kósa JP; Podani J; Horváth P; Nagy Z; Horányi J; Járay B; Székely E; Krenács L; Árvai K; Dank M; Putz Z; Szabó B; Szili B; Valkusz Z; Vasas B; Győri G; Lakatos P; Takács I
J Endocrinol Invest; 2015 Mar; 38(3):313-21. PubMed ID: 25201000
[TBL] [Abstract][Full Text] [Related]
10. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
11. Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.
Horvath E; Lakatos P; Balla B; Kósa JP; Tóbiás B; Jozilan H; Borka K; Horváth HC; Kovalszky I; Szalay F
Anticancer Res; 2012 Nov; 32(11):4791-6. PubMed ID: 23155244
[TBL] [Abstract][Full Text] [Related]
12. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1,25 and 24,25 Vitamin D on Corneal Fibroblast VDR and Vitamin D Metabolizing and Catabolizing Enzymes.
Lu X; Chen Z; Watsky MA
Curr Eye Res; 2021 Sep; 46(9):1271-1282. PubMed ID: 33535006
[No Abstract] [Full Text] [Related]
14. Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.
Ramnath N; Nadal E; Jeon CK; Sandoval J; Colacino J; Rozek LS; Christensen PJ; Esteller M; Beer DG; Kim SH
J Thorac Oncol; 2014 Apr; 9(4):473-82. PubMed ID: 24736069
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line.
Han J; Tang Y; Zhong M; Wu W
Mol Med Rep; 2019 Dec; 20(6):5064-5074. PubMed ID: 31638226
[TBL] [Abstract][Full Text] [Related]
16. Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.
Zou M; BinHumaid FS; Alzahrani AS; Baitei EY; Al-Mohanna FA; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2014 Jul; 81(1):109-16. PubMed ID: 24382015
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of the vitamin D metabolizing enzymes CYP27B1 and CYP24A1 under the context of prostate aging and pathologies.
Campolina-Silva GH; Barata MC; Werneck-Gomes H; Maria BT; Mahecha GAB; Belleannée C; Oliveira CA
J Steroid Biochem Mol Biol; 2021 May; 209():105832. PubMed ID: 33596463
[TBL] [Abstract][Full Text] [Related]
18. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.
Urbschat A; Paulus P; von Quernheim QF; Brück P; Badenhoop K; Zeuzem S; Ramos-Lopez E
Eur J Clin Invest; 2013 Dec; 43(12):1282-90. PubMed ID: 24245571
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
